Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2023-08-23 00:00:00 ET · period of report 2023-08-21 · accession 0001968202-23-000022 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-08-23 | 2023-08-21 | REGN | Bassler Bonnie L | Dir | M - OptEx | $391.92 | +853 | 2,100 | +68% | +$334.3K |
| D | 2023-08-23 | 2023-08-21 | REGN | Bassler Bonnie L | Dir | S - Sale+OE | $829.00 | -853 | 1,247 | -41% | -$707.1K |
| D | 2023-08-23 | 2023-08-21 | REGN | Bassler Bonnie L | Dir | M - OptEx | $0.00 | -853 | 854 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-21 | M | A | 853 | $391.92 | 2,100 | D | — | — | |
| 2 | Common | Common Stock | 2023-08-21 | S | D | 853 | $829.00 | 1,247 | D | — | — | |
| 3 | Derivative | Non-Qualified Stock Option (right to buy) | 2023-08-21 | M | D | 853 | $0.00 | 854 | D | $391.92 · — to 2026-09-09 | 853 Common Stock | (F2) The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant. |